Department of Anaesthesiology and Intensive Care Medicine, Eberhard-Karls University Tübingen, Hoppe-Seyler-Straße 3, 72076, Tübingen, Germany.
J Biomed Sci. 2024 Aug 21;31(1):82. doi: 10.1186/s12929-024-01074-x.
Intracellular sensing of lipopolysaccharide (LPS) is essential for the immune response against gram-negative bacteria and results in activation of caspase-11 and pyroptotic cell death with fatal consequences in sepsis. We found the neuronal guidance receptor plexin C1 (PLXNC1) influences the intracellular response to LPS.
We employed a murine model of sepsis via cecal ligation and binding (CLP), using PLXNC1-/- mice and littermate controls, and additionally transfected murine bone-marrow-derived macrophages (BMDMs) from both genotypes with LPS to achieve activation of the noncanonical inflammasome ex vivo. Additionally, we transfected the PLXNC1 ligand SL4c-d in vivo and ex vivo to examine its effect on intracellular LPS response.
We found the neuronal guidance receptor PLXNC1 dampens the intracellular response to LPS by interacting with adenylate cyclase 4 (ADCY4) and protein kinase A activity, which in turn diminishes caspase-11 expression. The absence of PLXNC1 results in excessive inflammation marked by increased cytokine release, increased secondary organ injury and reduced sepsis survival in a murine sepsis model induced by CLP. Notably, administration of SL4c-d-peptide ligand of PLXNC1-reduces the inflammatory response during CLP-induced sepsis and improves survival.
These results elucidate a previously unknown mechanism for PLXNC1 suppressing excessive noncanonical inflammasome activity and offer a new potential target for treatment of sepsis with its detrimental effects.
细胞内对脂多糖(LPS)的感应对于针对革兰氏阴性菌的免疫反应至关重要,导致半胱天冬酶-11 的激活和细胞焦亡性细胞死亡,在脓毒症中具有致命后果。我们发现神经元导向受体丛蛋白 C1(PLXNC1)影响细胞内对 LPS 的反应。
我们通过盲肠结扎和结合(CLP)在脓毒症的小鼠模型中使用 PLXNC1-/-小鼠及其同窝对照,并另外转染来自两种基因型的鼠骨髓源性巨噬细胞(BMDM)用 LPS 以实现非经典炎性小体的体外激活。此外,我们在体内和体外转染 PLXNC1 配体 SL4c-d,以检查其对细胞内 LPS 反应的影响。
我们发现神经元导向受体 PLXNC1 通过与腺苷酸环化酶 4(ADCY4)和蛋白激酶 A 活性相互作用来抑制细胞内对 LPS 的反应,这反过来又降低了半胱天冬酶-11 的表达。PLXNC1 的缺失导致细胞因子释放增加、继发性器官损伤增加和 CLP 诱导的脓毒症小鼠模型中存活减少,这表明炎症过度。值得注意的是,SL4c-d-PLXNC1 肽配体的给药可减少 CLP 诱导的脓毒症期间的炎症反应并提高存活率。
这些结果阐明了 PLXNC1 抑制过度非经典炎性小体活性的先前未知机制,并为其有害作用的脓毒症治疗提供了新的潜在靶点。